151 related articles for article (PubMed ID: 32716010)
21. Effect of neoadjuvant radiotherapy on survival of non-metastatic pancreatic ductal adenocarcinoma: a SEER database analysis.
Wang D; Liu C; Zhou Y; Yan T; Li C; Yang Q; Xu Y; Zhao L; Pei Q; Tan F; Güngör C; Li Y
Radiat Oncol; 2020 May; 15(1):107. PubMed ID: 32404114
[TBL] [Abstract][Full Text] [Related]
22. [Surgical therapy of pancreatic cancer - 5 years survival].
Loveček M; Skalický P; Klos D; Neoral Č; Ehrmann J; Zapletalová J; Švébišová H; Yogeswara T; Ghothim M; Vrba R; Havlík R
Rozhl Chir; 2015 Nov; 94(11):470-6. PubMed ID: 26766155
[TBL] [Abstract][Full Text] [Related]
23. Undifferentiated carcinoma with osteoclast-like giant cells: A pathologic-radiologic correlation of a rare histologic subtype of pancreatic ductal adenocarcinoma.
Jain PV; Griffin M; Hunt B; Ward E; Tsai S; Doucette S
Ann Diagn Pathol; 2022 Apr; 57():151884. PubMed ID: 35074581
[TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma.
Nitori N; Ino Y; Nakanishi Y; Yamada T; Honda K; Yanagihara K; Kosuge T; Kanai Y; Kitajima M; Hirohashi S
Clin Cancer Res; 2005 Apr; 11(7):2531-9. PubMed ID: 15814630
[TBL] [Abstract][Full Text] [Related]
25. Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring system.
Karamitopoulou E; Wartenberg M; Zlobec I; Cibin S; Worni M; Gloor B; Lugli A
Histopathology; 2018 Jul; 73(1):137-146. PubMed ID: 29495092
[TBL] [Abstract][Full Text] [Related]
26. Intraductal papillary mucinous neoplasms of the pancreas: an updated experience.
Sohn TA; Yeo CJ; Cameron JL; Hruban RH; Fukushima N; Campbell KA; Lillemoe KD
Ann Surg; 2004 Jun; 239(6):788-97; discussion 797-9. PubMed ID: 15166958
[TBL] [Abstract][Full Text] [Related]
27. Preoperative radiotherapy improves overall survival of pT4 pancreatic ductal adenocarcinoma patients after surgical resection.
Xu Y; Zhang Y; Wu Z; Wang D; Wu W; Kuang T; Lou W
Jpn J Clin Oncol; 2020 Jun; 50(6):679-687. PubMed ID: 32372083
[TBL] [Abstract][Full Text] [Related]
28. Neoadjuvant radiation followed by resection versus upfront resection for locally advanced pancreatic cancer patients: a propensity score matched analysis.
Chen X; Liu G; Wang K; Chen G; Sun J
Oncotarget; 2017 Jul; 8(29):47831-47840. PubMed ID: 28599299
[TBL] [Abstract][Full Text] [Related]
29. Origin of giant cells in osteoclast-like giant cell tumors of the pancreas.
Sakai Y; Kupelioglu AA; Yanagisawa A; Yamaguchi K; Hidaka E; Matsuya S; Ohbuchi T; Tada Y; Saisho H; Kato Y
Hum Pathol; 2000 Oct; 31(10):1223-9. PubMed ID: 11070115
[TBL] [Abstract][Full Text] [Related]
30. Association Between Very Small Tumor Size and Decreased Overall Survival in Node-Positive Pancreatic Cancer.
Muralidhar V; Nipp RD; Mamon HJ; Punglia RS; Hong TS; Ferrone C; Fernandez-Del Castillo C; Parikh A; Nguyen PL; Wo JY
Ann Surg Oncol; 2018 Dec; 25(13):4027-4034. PubMed ID: 30298331
[TBL] [Abstract][Full Text] [Related]
31. Undifferentiated carcinoma of the pancreas: analysis of intermediate filament profile and Ki-ras mutations provides evidence of a ductal origin.
Hoorens A; Prenzel K; Lemoine NR; Klöppel G
J Pathol; 1998 May; 185(1):53-60. PubMed ID: 9713360
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of valosin-containing protein (p97) is associated with lymph node metastasis and prognosis of pancreatic ductal adenocarcinoma.
Yamamoto S; Tomita Y; Hoshida Y; Nagano H; Dono K; Umeshita K; Sakon M; Ishikawa O; Ohigashi H; Nakamori S; Monden M; Aozasa K
Ann Surg Oncol; 2004 Feb; 11(2):165-72. PubMed ID: 14761919
[TBL] [Abstract][Full Text] [Related]
33. Osteoclastic and pleomorphic giant cell tumors of the pancreas diagnosed via EUS-guided FNA: unique clinical, endoscopic, and pathologic findings in a series of 5 patients.
Moore JC; Hilden K; Bentz JS; Pearson RK; Adler DG
Gastrointest Endosc; 2009 Jan; 69(1):162-6. PubMed ID: 19111699
[TBL] [Abstract][Full Text] [Related]
34. Temporal Assessment of Prognostic Factors in Patients With Pancreatic Ductal Adenocarcinoma Undergoing Neoadjuvant Treatment and Resection.
Ren W; Xourafas D; Ashley SW; Clancy TE
J Surg Res; 2021 Jan; 257():605-615. PubMed ID: 32947122
[TBL] [Abstract][Full Text] [Related]
35. Early-onset pancreatic cancer: a population-based study using the SEER registry.
Ansari D; Althini C; Ohlsson H; Andersson R
Langenbecks Arch Surg; 2019 Aug; 404(5):565-571. PubMed ID: 31377855
[TBL] [Abstract][Full Text] [Related]
36. Tumor location as an indicator of survival in T1 resectable pancreatic ductal adenocarcinoma: a propensity score-matched analysis.
Meng Z; Cao M; Zhang Y; Liu Z; Wu S; Wu H
BMC Gastroenterol; 2019 Apr; 19(1):59. PubMed ID: 31014264
[TBL] [Abstract][Full Text] [Related]
37. Lymph node evaluation for treatment of adenocarcinoma of the pancreas.
Marmor S; Burke EE; Portschy PR; Virnig BA; Jensen EH; Tuttle TM
Surg Oncol; 2015 Sep; 24(3):284-91. PubMed ID: 26303825
[TBL] [Abstract][Full Text] [Related]
38. Osteoclast-type giant cell tumour of the pancreas.
Fischer HP; Altmannsberger M; Kracht J
Virchows Arch A Pathol Anat Histopathol; 1988; 412(3):247-53. PubMed ID: 3124345
[TBL] [Abstract][Full Text] [Related]
39. Resected adenocarcinoma of the pancreas-616 patients: results, outcomes, and prognostic indicators.
Sohn TA; Yeo CJ; Cameron JL; Koniaris L; Kaushal S; Abrams RA; Sauter PK; Coleman J; Hruban RH; Lillemoe KD
J Gastrointest Surg; 2000; 4(6):567-79. PubMed ID: 11307091
[TBL] [Abstract][Full Text] [Related]
40. Albumin-to-alkaline phosphatase ratio serves as a prognostic indicator in unresectable pancreatic ductal adenocarcinoma: a propensity score matching analysis.
Zhang K; Dong S; Jing YH; Gao HF; Chen LY; Hua YQ; Chen H; Chen Z
BMC Cancer; 2020 Jun; 20(1):541. PubMed ID: 32517802
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
